Geode Capital Management
BLCM

Geode Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Geode Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-72,770
Closed -$24K – 4829
2023
Q1 		$24K Hold
72,770
– – ﹤0.01% 4667
2022
Q4 		$52K Sell
72,770
-155
-0.2% -$153 ﹤0.01% 4582
2022
Q3 		$87K Hold
72,925
– – ﹤0.01% 4622
2022
Q2 		$86K Hold
72,925
– – ﹤0.01% 4644
2022
Q1 		$157K Hold
72,925
– – ﹤0.01% 4491
2021
Q4 		$108K Sell
72,925
-3,608
-5% -$7.27K ﹤0.01% 4705
2021
Q3 		$223K Buy
76,533
+17,874
+30% +$54.5K ﹤0.01% 4405
2021
Q2 		$193K Buy
58,659
+27,259
+87% +$87.5K ﹤0.01% 4356
2021
Q1 		$118K Hold
31,400
– – ﹤0.01% 4267
2020
Q4 		$110K Sell
31,400
-13,464
-30% -$56.8K ﹤0.01% 4044
2020
Q3 		$294K Buy
44,864
+114
+0.3% +$773 ﹤0.01% 3604
2020
Q2 		$332K Buy
44,750
+3,595
+9% +$24.5K ﹤0.01% 3509
2020
Q1 		$190K Sell
41,155
-490
-1% -$5.26K ﹤0.01% 3568
2019
Q4 		$537K Buy
41,645
+6,386
+18% +$59K ﹤0.01% 3474
2019
Q3 		$370K Sell
35,259
-207
-0.6% -$2.71K ﹤0.01% 3578
2019
Q2 		$602K Sell
35,466
-16,405
-32% -$444K ﹤0.01% 3400
2019
Q1 		$1.75M Buy
51,871
+940
+2% +$31.4K ﹤0.01% 2930
2018
Q4 		$1.49M Buy
50,931
+8,452
+20% +$375K ﹤0.01% 2926
2018
Q3 		$2.62M Buy
42,479
+2,456
+6% +$166K ﹤0.01% 2735
2018
Q2 		$2.95M Buy
40,023
+17,273
+76% +$1.35M ﹤0.01% 2622
2018
Q1 		$1.49M Buy
22,750
+308
+1% +$23.3K ﹤0.01% 2929
2017
Q4 		$1.89M Buy
22,442
+315
+1% +$30.9K ﹤0.01% 2783
2017
Q3 		$2.56M Buy
22,127
+1,947
+10% +$205K ﹤0.01% 2606
2017
Q2 		$2.36M Buy
20,180
+2,279
+13% +$283K ﹤0.01% 2638
2017
Q1 		$2.21M Buy
17,901
+2,720
+18% +$356K ﹤0.01% 2614
2016
Q4 		$2.07M Sell
15,181
-1,283
-8% -$228K ﹤0.01% 2609
2016
Q3 		$3.28M Buy
16,464
+8,345
+103% +$1.44M ﹤0.01% 2236
2016
Q2 		$1.05M Buy
8,119
+1,652
+26% +$184K ﹤0.01% 2877
2016
Q1 		$604 Buy
6,467
+252
+4% +$27.4K ﹤0.01% 3124
2015
Q4 		$1.26M Sell
6,215
-55
-0.9% -$9.84K ﹤0.01% 2780
2015
Q3 		$911K Sell
6,270
-1,259
-17% -$231K ﹤0.01% 2925
2015
Q2 		$1.6M Buy
7,529
+78
+1% +$19.1K ﹤0.01% 2629
2015
Q1 		$1.73M Buy
+7,451
New +$1.8M ﹤0.01% 2535

Other funds holding BLCM

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Geode Capital Management's BLCM Position: Q2 2023 in Review

Geode Capital Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 72,770 shares — an estimated $24K sold.

Geode Capital Management first reported a position in BLCM in Q1 2015 and held it in 33 quarters. The position peaked at $3.28M in Q3 2016. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

  • Geode Capital Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Geode Capital Management sold 72,770 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $24K.
  • Geode Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 33 quarters.
  • Geode Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $3.28M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.